microdose glp-1 Exploring Microdosing Medications: Benefits Beyond Weight Loss Microdosing GLP-1 Drugs: What To
Description
Diabetes 59 (11), 26972707
Semaglutide is the active ingredient in Wegovy, and some legal complaints have been filed by past Wegovy patients who also say they experienced vision loss from a NAION after taking it
Pharmacological options with established evidence include acamprosate, naltrexone, and disulfiram for maintaining abstinence
doi: 10.1046/j.1365-2990.2002.00393.x
In summary, advancing from conceptual recognition to formal inclusion of PDM in global diabetes frameworks requires standardised definitions, digital innovation, and cross-disciplinary collaboration
Woodward, M.J
